Rafael Reis do Espírito Santos,Cezar Augusto Muniz Caldas,Jozélio Freire de Carvalho
Rafael Reis do Espírito Santos
Objective: Antiphospholipid syndrome (APS) is a disease characterized by recurrent thrombosis in the presence of antiphospholipid antibodies. The most uncommon events described in the literature have been peripheral neuro...
Autologous hematopoietic stem-cell transplantation in diffuse cutaneous systemic sclerosis: a single-center experience [0.03%]
自身造血干细胞移植治疗弥漫性皮肤系统硬化症：单中心经验报告
Marko Barešić,Ljiljana Smiljanić Tomičević,Igor Aurer et al.
Marko Barešić et al.
Systemic sclerosis (SSc) is a chronic autoimmune disorder characterized by multisystem involvement. Patients can be stratified into an indolent or rapidly progressive disease course. A progressive course warrants early and more aggressive t...
Kubra Kaynar,Şeymanur Serdar Kılıçaslan,Sevdegül Mungan et al.
Kubra Kaynar et al.
Sjögren's disease (SjD) was first described in a middle-aged female patient with chronic rheumatism in 1930. Membranous nephropathy (MN) is the most commonly identified type of glomerulonephritis in older adults with nephrotic syndrome. On...
A comprehensive evaluation of the transition to a biosimilar of adalimumab in rheumatoid arthritis and psoriatic arthritis: a single-center experience with a focus on imaging outcomes [0.03%]
全面评估adalimumab生物类似药在类风湿性关节炎和银屑病关节炎中的转换：一项单一中心的经验，重点关注影像学结果
Rodrigo Garcia-Salinas,Sebastian Magri,Alvaro Ruta et al.
Rodrigo Garcia-Salinas et al.
Objective: Limited data in Latin America exists regarding the efficacy of switches from original biologicals to biosimilars in real-life scenarios. Currently, no studies assess this switch using imaging. The objective of ...
Real-life effectiveness of rituximab in different subsets of idiopathic inflammatory myopathies [0.03%]
利妥昔单抗在不同特发性炎性肌病亚型中的疗效研究
Stefano Stano,Fabio Cacciapaglia,Laura Coladonato et al.
Stefano Stano et al.
Objective: Idiopathic inflammatory myopathies (IIM) are heterogeneous autoimmune diseases including dermatomyositis (DM), polymyositis (PM), immune-mediated necrotizing myopathy (IMNM), and anti-synthetase syndrome (ASS)....
The role of leukemia inhibitory factor in autoimmune disorders: insights into recovery and treatment [0.03%]
白细胞抑制因子在自身免疫性疾病中的作用：对恢复和治疗的启示
Zahra Rodgarpoor,Ahmad Meshkin,Mohammadamin Ehramianpour et al.
Zahra Rodgarpoor et al.
Objective: Leukemia inhibitory factor (LIF) is a multifunctional cytokine involved in numerous physiological processes, including inflammation and immune response regulation. Recent studies have highlighted its potential ...
Alfonse T. Masi [0.03%]
阿尔方斯·T·马西
Maurizio Cutolo
Maurizio Cutolo
Alfonse T. Masi (born October 1930) passed away peacefully and comfortably in his home in March 2025 at the age of 94 years after a prestigious career...
Luis Carlos Palomino Romero,Alfredo Vargas Caselles,Natalia Soledad Rius et al.
Luis Carlos Palomino Romero et al.
Patients with dermatomyositis (DM) are particularly susceptible to the development of opportunistic infections due to immunosuppression induced by the disease itself and its treatment. We describe three patients who met the diagnostic crite...
Prevalence of musculoskeletal disorders in patients referred for suspected deep vein thrombosis: insights from a rheumatologist-led clinic [0.03%]
疑似深静脉血栓形成转诊患者的肌肉骨骼疾病患病率：风湿病专家门诊的见解
Nikoletta Svendsen,Philip Rask Lage-Hansen,Stavros Chrysidis
Nikoletta Svendsen
Objective: To assess the frequency of deep vein thrombosis (DVT) and alternative diagnoses in patients with suspected DVT when evaluated by a rheumatologist. Secondly, to describe the distribution of different diagnoses a...
After what time interval are we justified to diagnose immune checkpoint inhibitor-mediated polymyalgia rheumatica? [0.03%]
我们何时可以诊断免疫检查点抑制剂介导的多肌炎？
Ciro Manzo,Marco Isetta
Ciro Manzo
Dear Editor, the number of cases of cancer patients diagnosed as having immune checkpoint inhibitor-mediated polymyalgia rheumatica has been steadily rising in published reports. However, the lack of a validated scale or algorithm is still ...